BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36818463)

  • 1. One-step versus two-step screening for diagnosis of gestational diabetes mellitus in Iranian population: A randomized community trial.
    Ramezani Tehrani F; Rahmati M; Farzadfar F; Abedini M; Farahmand M; Hosseinpanah F; Hadaegh F; Torkestani F; Valizadeh M; Azizi F; Behboudi-Gandevani S
    Front Endocrinol (Lausanne); 2022; 13():1039643. PubMed ID: 36818463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and diagnosing gestational diabetes mellitus.
    Hartling L; Dryden DM; Guthrie A; Muise M; Vandermeer B; Aktary WM; Pasichnyk D; Seida JC; Donovan L
    Evid Rep Technol Assess (Full Rep); 2012 Oct; (210):1-327. PubMed ID: 24423035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Various screening and diagnosis approaches for gestational diabetes mellitus and adverse pregnancy outcomes: a secondary analysis of a randomized non-inferiority field trial.
    Ramezani Tehrani F; Sheidaei A; Rahmati M; Farzadfar F; Noroozzadeh M; Hosseinpanah F; Abedini M; Hadaegh F; Valizadeh M; Torkestani F; Khalili D; Firouzi F; Solaymani-Dodaran M; Ostovar A; Azizi F; Behboudi-Gandevani S
    BMJ Open Diabetes Res Care; 2023 Dec; 11(6):. PubMed ID: 38164706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does fasting plasma glucose values 5.1-5.6 mmol/l in the first trimester of gestation a matter?
    Ramezani Tehrani F; Farzadfar F; Hosseinpanah F; Rahmati M; Firouzi F; Abedini M; Hadaegh F; Valizadeh M; Torkestani F; Khalili D; Solaymani-Dodaran M; Bidhendi-Yarandi R; Bakhshandeh M; Ostovar A; Dovom MR; Amiri M; Azizi F; Behboudi-Gandevani S
    Front Endocrinol (Lausanne); 2023; 14():1155007. PubMed ID: 37334302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain after diagnosis of gestational diabetes mellitus and its association with adverse pregnancy outcomes: a cohort study.
    Zheng W; Huang W; Liu C; Yan Q; Zhang L; Tian Z; Yuan X; Li G
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):216. PubMed ID: 33731035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cluster Randomized Noninferiority Field Trial of Gestational Diabetes Mellitus Screening.
    Ramezani Tehrani F; Behboudi-Gandevani S; Farzadfar F; Hosseinpanah F; Hadaegh F; Khalili D; Soleymani-Dodaran M; Valizadeh M; Abedini M; Rahmati M; Bidhendi Yarandi R; Torkestani F; Abdollahi Z; Bakhshandeh M; Zokaee M; Amiri M; Bidarpour F; Javanbakht M; Nabipour I; Nasli Esfahani E; Ostovar A; Azizi F
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e2906-e2920. PubMed ID: 35325164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review.
    Sermer M; Naylor CD; Farine D; Kenshole AB; Ritchie JW; Gare DJ; Cohen HR; McArthur K; Holzapfel S; Biringer A
    Diabetes Care; 1998 Aug; 21 Suppl 2():B33-42. PubMed ID: 9704225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational diabetes mellitus, pre-pregnancy body mass index and gestational weight gain predicts fetal growth and neonatal outcomes.
    Teshome AA; Li Q; Garoma W; Chen X; Wu M; Zhang Y; Zhang X; Lin L; Wang H; Yang X; Hao L; Sun G; Han W; Chen X; Xiong G; Yang N
    Clin Nutr ESPEN; 2021 Apr; 42():307-312. PubMed ID: 33745597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of different screening strategies for gestational diabetes mellitus screening: study protocol of a randomized community non-inferiority trial.
    Ramezani Tehrani F;
    Diabetol Metab Syndr; 2019; 11():106. PubMed ID: 31890040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One abnormal value or vomiting after oral glucose tolerance test in pregnancy: incidence and impact on maternal-fetal outcomes.
    Navarro-Martinez H; Flores-Le Roux JA; Llauradó G; Gortazar L; Payà A; Mañé L; Pedro-Botet J; Benaiges D
    Gynecol Endocrinol; 2023 Dec; 39(1):2242951. PubMed ID: 37550858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-pregnancy dysglycemia in obese pregnancies after negative testing for gestational diabetes and risk of future childhood overweight: An interim analysis from a longitudinal mother-child cohort study.
    Gomes D; von Kries R; Delius M; Mansmann U; Nast M; Stubert M; Langhammer L; Haas NA; Netz H; Obermeier V; Kuhle S; Holdt LM; Teupser D; Hasbargen U; Roscher AA; Ensenauer R
    PLoS Med; 2018 Oct; 15(10):e1002681. PubMed ID: 30372451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening.
    Hillier TA; Pedula KL; Ogasawara KK; Vesco KK; Oshiro CES; Lubarsky SL; Van Marter J
    N Engl J Med; 2021 Mar; 384(10):895-904. PubMed ID: 33704936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the National Diabetes Data Group and the Carpenter-Coustan criteria for assessing gestational diabetes mellitus and risk of adverse pregnancy outcome.
    Lu MC; Huang SS; Yan YH; Wang P
    BMC Pregnancy Childbirth; 2016 Aug; 16():231. PubMed ID: 27535366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric and perinatal outcomes of singleton pregnancies conceived via assisted reproductive technology complicated by gestational diabetes mellitus: a prospective cohort study.
    Kouhkan A; Khamseh ME; Pirjani R; Moini A; Arabipoor A; Maroufizadeh S; Hosseini R; Baradaran HR
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):495. PubMed ID: 30547777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of obstetric and neonatal morbidity in gestational diabetes in a single institution: A retrospective, observational study.
    Chung YS; Moon H; Kim EH
    Medicine (Baltimore); 2022 Sep; 101(39):e30777. PubMed ID: 36181034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Maternal and Neonatal Complications in a Group of Patients with Gestational Diabetes Mellitus.
    Preda A; Pădureanu V; Moța M; Ștefan AG; Comănescu AC; Radu L; Mazilu ER; Vladu IM
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833388
    [No Abstract]   [Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, risk factors, and pregnancy outcomes of gestational diabetes mellitus using one-step versus two-step diagnostic approaches: A population-based cohort study in Isfahan, Iran.
    Hosseini E; Janghorbani M; Aminorroaya A
    Diabetes Res Clin Pract; 2018 Jun; 140():288-294. PubMed ID: 29649540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of gestational diabetes and its association with stillbirth, preterm birth, macrosomia, abortion and cesarean delivery: a national prevalence study of 11 provinces in Iran.
    Darbandi M; Rezaeian S; Dianatinasab M; Yaghoobi H; Soltani M; Etemad K; Valadbeigi T; Taherpour N; Hajipour M; Saeidi R
    J Prev Med Hyg; 2021 Dec; 62(4):E885-E891. PubMed ID: 35603250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The World Health Organization (WHO) versus The International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes.
    Basri NI; Mahdy ZA; Ahmad S; Abdul Karim AK; Shan LP; Abdul Manaf MR; Ismail NAM
    Horm Mol Biol Clin Investig; 2018 Feb; 34(1):. PubMed ID: 29453924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.